Related Experiment Video
Updated: Jul 20, 2026
08:04
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Cyclosporine-induced apoptosis in osteosarcoma cells
1Department of Obstetrics and Gynecology, Kosin University Medical College, Pusan, Korea.
Transplantation Proceedings
|September 19, 2006
Summary
Cyclosporine (CsA) treatment can harm bone health after kidney transplants. This study found that CsA induces programmed cell death (apoptosis) in rat osteoblasts, explaining some bone disease mechanisms.
Area of Science:
- Biomedical Science
- Immunosuppression Research
- Bone Metabolism
Background:
- Posttransplant bone disease is a known complication of cyclosporine (CsA) immunosuppression.
- The exact mechanisms by which CsA causes osteopenia remain unclear.
- CsA is vital for preventing organ rejection in kidney transplant recipients.
Purpose of the Study:
- To investigate the effect of CsA on osteoblast apoptosis.
- To elucidate the molecular pathways involved in CsA-induced osteoblast cell death.
Main Methods:
- Utilized a rat osteoblast cell line (ROS 17/2.8).
- Assessed cell viability using MTT assay.
- Analyzed protein expression changes via Western blot, focusing on apoptosis-related markers.
Main Results:
- CsA demonstrated dose-dependent cytotoxic effects on osteoblasts.
- CsA treatment increased the expression of pro-apoptotic proteins (caspase-8, Bax, p53, cleaved PARP).
- CsA decreased the expression of anti-apoptotic protein Bcl-2 and pro-caspase-3.
Conclusions:
- CsA induces apoptosis in osteoblasts.
- These findings suggest a mechanism for CsA-induced osteopenia in transplant patients.
More Related Videos
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...